COMMUNIQUÉS West-GlobeNewswire

Lexington Begins HeartSentry Clinical Trial
20/02/2018
VANCOUVER, British Columbia, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is pleased to announce [...]
Predictive Technology Group, Inc. (PRED) Announces Completion of Genotyping in Two Clinical Trials of ARTGuide™
20/02/2018
SALT LAKE CITY, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC PINK:PRED) announces that Predictive Therapeutics, LLC , its wholly-owned subsidiary, completed a crucial milestone in the [...]
Burcon Congratulates Protein Industries Canada
20/02/2018
VANCOUVER, British Columbia, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Burcon NutraScience Corporation (TSX: BU ) (NASDAQ: BUR ) (“Burcon” or the “Corporation”), a leader in natural product extraction, purification and [...]
In Midst of Flu Epidemic, Teladoc Provides Relief for Overburdened Health System
20/02/2018
PURCHASE, NY, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Teladoc , Inc. (NYSE: TDOC ), the world’s largest and most trusted provider of virtual care delivery services, announced today that amid the most severe flu outbreak in a [...]
Xenon Pharmaceuticals Advances Second Proprietary Epilepsy Product into the Clinic with Initiation of XEN901 Phase 1 Clinical Trial
20/02/2018
BURNABY, British Columbia, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE ), a clinical-stage biopharmaceutical company, today announced the initiation of a Phase 1 clinical trial of its [...]
Onconova Announces Two Presentations at 2018 American Chemical Society National Meeting and Expo
20/02/2018
Product stability studies for rigosertib, a Phase 3 clinical stage product in development for Myelodysplastic Syndromes (MDS) Discovery of a novel kinase inhibitor, ON 150030, a Type 1 inhibitor of FLT3 and Src for [...]
Marrone Bio Innovations Announces The Netherlands as New Rapporteur Member State for Sakalia
20/02/2018
DAVIS, Calif., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII ) (MBI), a leading provider of bio-based pest management and plant health products for agriculture, turf and ornamental and [...]
Histogenics Corporation to Present at Upcoming Investor Conferences
20/02/2018
WALTHAM, Mass., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq: HSGX ), a leader in the development of restorative cell therapies that may offer rapid-onset pain relief and restored [...]
Acology’s Perfect Package: MedTainer Confirmed Compliant for US, Canada and Mexico
20/02/2018
CORONA, Calif, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Acology Inc. (OTCMARKETS:ACOL) confirmed today that its signature product, the MedTainer™, is compliant for the entire North American market, and specifically for the [...]
Nuvectra Secures $45 Million Second Amendment to Existing Loan and Security Agreement
20/02/2018
PLANO, Texas, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR ), a neurostimulation medical device company, announced today that it has reached an agreement with Silicon Valley Bank and Oxford [...]
Athenex Announces Phase II Clinical Study Results for KX2-391 Ointment for the Treatment of Actinic Keratosis in the American Academy of Dermatology Meeting
20/02/2018
BUFFALO, N.Y., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Athenex (Nasdaq: ATNX ), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer [...]
Quotient Limited Announces Appointment of Franz Walt as Non-Executive Director
20/02/2018
JERSEY, Channel Islands, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT ), a commercial-stage diagnostics company, today announced the appointment of Franz Walt to its board of directors effective [...]
T2 Biosystems Announces 2017 Fourth Quarter and Full-Year Financial and Operational Results Release and Conference Call Date
20/02/2018
LEXINGTON, Mass., Feb. 20, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO ) an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in [...]
AveXis to Report Fourth Quarter and Full Year 2017 Financial and Operating Results
20/02/2018
CHICAGO, Feb. 20, 2018 (GLOBE NEWSWIRE) -- AveXis, Inc. (NASDAQ: AVXS ), a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic diseases, [...]
AMAG Pharmaceuticals to Host Fourth Quarter and Full Year 2017 Financial Results Conference Call and Webcast on Tuesday, February 27, 2018 at 8:00 a.m. ET
20/02/2018
WALTHAM, Mass., Feb. 20, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG ) today announced that its fourth quarter and full year 2017 financial results will be released on Tuesday, February 27, 2018 [...]
PositiveID to Exhibit its Caregiver Non-Contact Thermometer at EMS Today, a Journal of Emergency Medical Services Conference and Exposition, February 21-23
20/02/2018
DELRAY BEACH, Fla., Feb. 20, 2018 (GLOBE NEWSWIRE) -- PositiveID Corporation (OTC:PSID), a life sciences company focused on detection and diagnostics, announced today that its Thermomedics subsidiary will exhibit the [...]
resTORbio to Present at the 2018 RBC Capital Markets Global Healthcare Conference
20/02/2018
BOSTON, Feb. 20, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (NASDAQ: TORC ), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of aging- [...]
3D Signatures Inc. Announces Positive Topline Results of Development Trial Assessing its Telo-HL™ Test for Hodgkin’s Lymphoma
20/02/2018
TORONTO, Feb. 20, 2018 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSX-V: DXD ) (OTCQB:TDSGF) (FSE:3D0) (the " Company " or " 3DS ") is pleased to announce that a preliminary third-party analysis of the trial data for [...]
Premier Biomedical Pain Relief Products Now Sold Through Okeechobee Discount Drugs
20/02/2018
JACKSON CENTER, Pa., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Premier Biomedical, Inc. (OTC:BIEI) announced today they have signed a distribution agreement with Okeechobee Discount Drugs to sell and distribute Premier’s pain [...]

Pages